the medical oncology section
Dr. Edward Chu, professor of internal medicine and pharmacology at the School of Medicine, has been named chief of the Section of Medical Oncology at the Yale Cancer Center, according to an announcement by Dr. Richard Edelson, the center's director.
Chu will be responsible for the clinical and research activities of the section which is now poised for substantial faculty expansion and programmatic development. Medical School Dean Dr. Robert Alpern said, "We are extremely fortunate to have someone with Dr. Chu's experience and talent to lead us forward in medical oncology. This program is central to our outstanding programs in cancer research."
Edelson noted that Chu was selected after a "a careful national search" by a committee of senior leaders. "Dr. Chu brings a special blend of clinical skills, major accomplishments as an innovative cancer researcher, familiarity with our school and hospital, and demonstrated leadership talents to the center," Edelson said.
Among Chu's first tasks will be recruiting new clinical oncologists and enhancing the translational clinical research program. These recruitment efforts will be coordinated with the leadership of the Yale Cancer Center, the Department of Internal Medicine and other major clinical and basic research cancer units at the School of Medicine and Yale-New Haven Hospital.
Chu has earned international acclaim for his seminal research in fundamental aspects of aberrant cellular proliferation in cancer. Currently he and his research team are actively involved in developing novel compounds and strategies for the treatment of colorectal cancer as well as other human malignancies. Chu is the author of the "Physicians' Cancer Chemotherapy Drug Manual," which provides a comprehensive review of all major cancer drugs and drug treatment regimens currently used in daily clinical practice by medical oncologists and health care professionals.
Formerly a tenured senior clinical investigator at the National Cancer Institute, Chu came to Yale in 1996 as chief of medical oncology and director of the VACT Cancer Center at the West Haven Veterans Administration Hospital, and as co-director of the Developmental Therapeutics Research Program at the Cancer Center.
T H I S
W E E K ' SS T O R I E S
Gift from alumnus helps fund new home for F&ES
Team learns how bacteria evades body's defenses
Grants will advance research on important health issuesPreventing HIV infection in India's at-risk populations
Understanding the causes of autism in infants
Treating patients with MS and spinal cord injuries
Brain power
ENDOWED PROFESSORSHIPSJohn Hartwig is Irénée duPont Professor of Chemistry
Shelly Kagan named Clark Professor of Philosophy
Jay Winter designated as the Stille Professor of History
Keith Wrightson is the Townsend Jr. Professor of History
Wimbledon winner, future Olympians to compete in Pilot Pen tournament
IN FOCUS: Yale Health Plan
Works by Cuban artists on view in 'Intersections/Intersecciones' exhibit
Bouchet Award recognizes scientist's effort to promote diversity
F&ES hosts delegation from China
Deserts, rainforests equally productive during drought, says study
EPA certificate of recognition awarded to Yale power plant
IN MEMORIAM: Edmund Slocum Crelin Jr.: newborn anatomy expert
CANCER CENTER APPOINTMENTSDr. Ira Mellman, new scientific director, will enhance partnership
Dr. Edward Chu will oversee the medical oncology section
Researchers receive grants for studies on women's health issues
New 'advocates' for theater are named to council
Genetics professor wins award to study prostate cancer . . .
Nursing professor Kathleen Knafl to chair group . . .
Art Gallery's new development director to head . . .
Yale Books in Brief
Campus Notes
Bulletin Home|Visiting on Campus|Calendar of Events|In the News
Bulletin Board|Classified Ads|Search Archives|Deadlines
Bulletin Staff|Public Affairs|News Releases|
E-Mail Us|Yale Home